CategoryMedical & Pharma
8th European Congress on Infectious Diseases
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 8th European Congress on Infectious Diseases — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
21st World Conference on Infectious Diseases, Prevention and Control
Date: August 27–28, 2026
Venue: Webinar (Online)
Event Type: Medical & Healthcare Conference, Academic Symposium, Global Public Health Summit
1️⃣ Who attends (BUYERS / ATTENDEES)
This event attracts a global audience of professionals focused on infectious diseases, public health, and medical research. Key attendee profiles include:
- Researchers and scientists in microbiology, virology, and epidemiology
- Clinicians and healthcare providers specializing in infectious diseases
- Epidemiologists and public health officials
- Academicians and educators in medical sciences
- Government and NGO representatives in health policy
- Pharmaceutical and biotechnology industry professionals
- Medical device and diagnostic equipment manufacturers
2️⃣ Location + Attendee Geographic Origin
Event Location: Virtual (Webinar)
Attendee Origin: Global. While the webinar format enables worldwide participation, the event emphasizes connections across Europe, UK, USA, Middle East, Asia, and Africa. Key participants include:
- European health ministries and research institutions
- North American pharmaceutical and biotech companies
- Asian medical device manufacturers
- African public health organizations
3️⃣ Audience Reach
Reach Type: Global. As a webinar hosted by Conference Series, this event leverages digital platforms to connect stakeholders worldwide. Marketing efforts target:
- Medical universities and research centers globally
- Government health departments across continents
- International NGOs and health advocacy groups
- Corporate entities in pharmaceuticals, diagnostics, and healthcare technology
4️⃣ Sample Buyer Company Names + Websites
Potential high-value buyers based on event focus and industry alignment:
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Pfizer Inc. | https://www.pfizer.com | Director, Infectious Disease Research | Global pharmaceutical leader in vaccine and antiviral development |
| 2 | Johnson & Johnson | https://www.jnj.com | Head of Global Health Initiatives | Major investor in pandemic preparedness and public health programs |
| 3 | Becton, Dickinson and Company (BD) | https://www.bdzones.com | Sr. Manager, Diagnostic Solutions | Leading medical technology firm in infection control and diagnostic equipment |
| 4 | World Health Organization (WHO) | https://www.who.int | Program Manager, Pandemic Response | Global authority on public health policy and disease surveillance |
| 5 | Thermo Fisher Scientific | https://www.thermofisher.com | Director, Clinical Diagnostics | Key supplier of laboratory equipment for infectious disease testing |
| 6 | GlaxoSmithKline (GSK) | https://www.gsk.com | VP, Vaccines R&D | Pharmaceutical company with extensive infectious disease vaccine portfolio |
| 7 | Centers for Disease Control and Prevention (CDC) | https://www.cdc.gov | Chief of Infectious Diseases Division | U.S. federal agency leading national and international disease control efforts |
| 8 | Sanofi Pasteur | https://www.sanofi.com | Global Head, Vaccine Development | One of the world’s largest vaccine manufacturers |
| 9 | Abbott Laboratories | https://www.abbott.com | Sr. Director, Diagnostics | Provider of rapid diagnostic tests for infectious diseases |
| 10 | Bill & Melinda Gates Foundation | https://www.gatesfoundation.org | Program Officer, Global Health | Major funder of infectious disease research and eradication programs |
5️⃣ Job Profiles, Industries & Event Type
Key Job Profiles:
- Epidemiologist
- Infectious Disease Specialist
- Public Health Official
- Medical Researcher
- Vaccine Development Scientist
- Health Policy Advisor
- Diagnostic Equipment Procurement Manager
Best Apollo Industries:
- Biotechnology
- Pharmaceuticals
- Medical Devices
- Hospital & Health Care
- Government Administration
Data sheet
8th European Congress on Infectious Diseases – Event Attendee & Buyer Profile Analysis
Event date: August 27–28, 2026
Location: Webinar / Online
Event status: Upcoming
Research date: June 30, 2026
Verification note: The supplied event title and location details provided by the requester could not be validated against the reviewed official event webpage. The primary official source reviewed corresponds to the 21st World Conference on Infectious Diseases, Prevention and Control, scheduled as a Webinar on August 27–28, 2026. The official source reviewed did not verify Budapest, Hungary, Radisson Hotel Budapest, BudaPart, or September 24–25, 2026 for this page.
Event Overview
| Event Name | 21st World Conference on Infectious Diseases, Prevention and Control (official page reviewed). Requested title “8th European Congress on Infectious Diseases” not verified from the provided official source. |
| Event Date | August 27–28, 2026 |
| Event Status | Upcoming |
| Venue | Webinar / Online |
| City | Not applicable for the official page reviewed |
| State / Region | Not publicly confirmed by the organizer in the reviewed source |
| Country | Not applicable for the official page reviewed; event stated as Webinar |
| Organizer | Conference Series |
| Official Event Website | infectious-diseases.conferenceseries.com/europe/ |
| Event Type | Medical conference / scientific symposium / public health webinar |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for attendee volume; high for date, format, organizer, and thematic focus based on official website text |
| Main Purpose of Event | To convene researchers, clinicians, epidemiologists, public health professionals, and industry participants to discuss infectious disease prevention, diagnosis, treatment, outbreak control, surveillance, vaccination, and global health collaboration. |
About the Event
Based on the reviewed official webpage, this event is positioned as the 21st World Conference on Infectious Diseases, Prevention and Control and is scheduled as a webinar on August 27–28, 2026. The conference theme emphasizes prevention, disease surveillance, diagnosis, treatment, outbreak control, vaccination, and public health strategy. The event is designed primarily for scientific exchange, knowledge sharing, and professional networking across the infectious disease ecosystem.
From a commercial and lead-generation perspective, this is more of a content-led medical and public health conference than a classic sourcing expo. That said, it is still relevant for organizations selling clinical diagnostics, laboratory technologies, pharmaceuticals, vaccine platforms, epidemiology software, infection prevention solutions, and health research services because attendees are likely to include decision influencers, principal investigators, clinicians, and public-sector health stakeholders.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Infectious disease clinicians | Hospitals, academic medical centers, specialist clinics | Clinical evaluation, treatment pathway influence, protocol adoption | High relevance for diagnostics, therapeutics, antimicrobial stewardship, and infection control vendors |
| Researchers and principal investigators | Universities, research institutes, translational medicine centers | Specification influence, grant-led purchasing input, collaboration partnerships | High relevance for lab technologies, assay platforms, sequencing, bioinformatics, CROs, and research services |
| Epidemiologists and surveillance specialists | Public health agencies, NGOs, academic groups | Influence over surveillance tools, reporting systems, analytics platforms | Relevant for public health software, data analytics, outbreak monitoring, and GIS-enabled health tools |
| Public health officials | Health ministries, disease control agencies, municipal health departments | Policy influence, program design, procurement input for public health interventions | Relevant for vaccination programs, surveillance systems, rapid diagnostics, and preparedness solutions |
| Pharmaceutical and biotech professionals | Drug developers, vaccine companies, biotech firms | Partnership, licensing, trial collaboration, scientific evaluation | Relevant for CROs, CDMOs, biomarker firms, diagnostics partners, and R&D collaboration providers |
| Medical device and diagnostics stakeholders | Diagnostic manufacturers, lab device firms, infection control product providers | Product adoption influence, distribution partnerships, clinical feedback | High relevance for test kits, instruments, sample handling, and point-of-care technologies |
| Academicians and educators | Medical schools, public health faculties, continuing education bodies | Curriculum and thought leadership influence | Relevant for publication, training, simulation, and academic partnership suppliers |
| NGO and international health program teams | Global health NGOs, donor-funded health initiatives | Programmatic buyer influence and field implementation decision support | Relevant for disease prevention tools, field diagnostics, training, and population health solutions |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Virtual host format | Global online participation | Distributed across healthcare, academia, and public health organizations | Official source states Webinar; no physical host city validated on the reviewed page |
| Europe | Likely strong participation from European hospitals, universities, and public health bodies | High | The web page references Europe and UK in its positioning and recommended conference network |
| United Kingdom | Likely participants from UK infectious disease and public health communities | Medium to High | UK appears in page title metadata, but not as a confirmed physical host location for this edition |
| North America | Likely attendance from research, pharma, and biotech stakeholders | Medium | Typical for global medical webinars; current-year attendee geography not publicly listed |
| Asia / Middle East | Likely participation from healthcare researchers, ministries, and manufacturers | Medium | Mentioned in page title and recommended regional conference network references |
| Africa and other global markets | Likely selective participation from international public health and NGO communities | Medium | Global health topics typically attract broad international interest, but no official geography split is published |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The event is explicitly described as a webinar welcoming participants from around the world, making its practical audience reach global rather than city-based or national. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| No current-year buyer organizations publicly confirmed in the reviewed official source | Not publicly disclosed | The official webpage reviewed provides event theme, organizer, and date/format information, but does not publish a verified attendee, buyer, sponsor, exhibitor, or speaker-organization list in the supplied source content. | N/A | N/A | Confirmed public list unavailable |
This event is not currently suitable for confirmed attendee-list building from public sources alone. It is better suited for role-based prospecting into likely attendee segments unless the organizer publishes a speaker roster, partner list, or sponsor directory later.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Infectious Disease Director | Clinical / Medical | Director | Strong influence over treatment pathways, diagnostics adoption, and specialist partnerships |
| 2 | Chief Medical Officer | Executive / Medical Affairs | C-Level | Relevant for enterprise-level clinical strategy and partnership discussions |
| 3 | Head of Epidemiology | Public Health / Research | Head / Director | Key contact for surveillance, analytics, and population health tools |
| 4 | Principal Investigator | Research | Manager / Director / Individual Contributor | Important for lab platform selection, study collaboration, and grant-funded acquisitions |
| 5 | Director of Infection Prevention and Control | Clinical Operations / Quality | Director | Relevant buyer/influencer for infection control technologies and workflow solutions |
| 6 | Public Health Program Manager | Government / Public Health | Manager | Relevant for prevention programs, digital reporting, and community implementation tools |
| 7 | Medical Affairs Director | Medical Affairs | Director | Important for scientific partnerships and post-market evidence programs |
| 8 | Laboratory Director | Laboratory Operations | Director | Key decision-maker for instruments, assays, workflow systems, and testing capability expansion |
| 9 | Clinical Research Manager | Clinical Research | Manager | Relevant for studies, trial logistics, sample processing, and external vendor selection |
| 10 | Global Health Partnerships Director | Partnerships / Programs | Director | Relevant for NGO, foundation, and public-private collaboration opportunities |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core attendee base for clinical infectious disease practice | Diagnostics, infection control, hospital surveillance solutions |
| 2 | Pharmaceuticals | Relevant for anti-infectives, vaccines, and clinical development | Scientific partnerships, trials, market education |
| 3 | Biotechnology | Strong fit for pathogen research, vaccines, and assay innovation | R&D collaboration and technical buyer outreach |
| 4 | Medical Devices | Diagnostics and monitoring tools are highly relevant | Point-of-care testing, lab systems, infection prevention equipment |
| 5 | Research | Academic and scientific attendance is central to the event theme | Lab tools, publications, data services, collaborations |
| 6 | Higher Education | Medical faculties and public health schools are likely attendee pools | Academic engagement and research platform sales |
| 7 | Government Administration | Public health agencies and ministries may participate | Surveillance, preparedness, and policy implementation tools |
| 8 | Nonprofit Organization Management | Global health nonprofits and disease initiatives are likely relevant | Program delivery, diagnostics deployment, health training |
| 9 | Health, Wellness & Fitness | Relevant for preventive health and population awareness stakeholders | Education, prevention, and community health engagement |
| 10 | Information Technology & Services | Relevant where disease surveillance, data platforms, and digital health analytics are involved | Public health informatics, dashboards, outbreak reporting systems |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | Official page reviewed does not disclose attendee count | No reliable numeric estimate should be stated from the supplied source |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No exhibitor directory in supplied official text | Appears more conference/webinar oriented than exhibition-led |
| Buyer count | Not publicly confirmed | Unconfirmed | No buyer registration breakdown published | This event likely attracts influencers more than dedicated procurement delegations |
| Speaker count | Not publicly confirmed in the supplied source text | Unconfirmed | Official page references distinguished speakers and leading experts | No numeric roster provided in the reviewed content |
| Sponsor count | Not publicly confirmed | Unconfirmed | No sponsor listing in supplied source content | Requires later verification if sponsor page is published |
| Historical attendance | Not available from the supplied official text | Historical / prior-year evidence unavailable | No prior-year attendance number cited in reviewed content | No dependable year-over-year trend can be stated |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Infectious disease prevention | Reduce transmission and improve preparedness | Educational webinars, protocol tools, evidence-based product briefings | Infection control products, training platforms, preventive technologies |
| Diagnosis and testing | Faster and more accurate detection | Clinical validation messaging and instrument demonstrations | Diagnostics, assay kits, molecular platforms, sample prep systems |
| Treatment and therapeutics | Improve patient outcomes and resistance management | Medical affairs outreach, KOL engagement, clinical evidence sharing | Pharmaceuticals, biologics, stewardship support tools |
| Disease surveillance systems | Track outbreaks and improve reporting | Public health software demos and interoperability discussions | Analytics, dashboards, epidemiology software, reporting infrastructure |
| Vaccination and immunization | Program design, outreach, delivery optimization | Partnerships with health agencies and public program leaders | Vaccines, cold-chain support, registry tools, awareness platforms |
| Outbreak control and pandemic preparedness | Readiness planning and rapid response capability | Scenario-based engagement with public health and hospital leaders | Preparedness solutions, emergency response tools, communication systems |
| Scientific exchange and research collaboration | Access to collaborators and current research directions | Abstract-linked outreach and PI networking | CRO services, lab partnerships, data analysis, publication support |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Relevant for healthcare, diagnostics, pharma, biotech, and public health solution providers |
| Decision-maker availability | Medium | Likely includes strong technical and clinical influencers; less certainty on direct procurement attendance |
| Data collection potential | Low | Public attendee and sponsor data is not currently available in the reviewed source |
| Apollo targeting potential | High | Strong role-based and industry-based targeting is possible even without a confirmed attendee list |
| Geographic targeting potential | High | Webinar format supports pan-regional prospecting across Europe and other global health markets |
| Best outreach approach | High | Use thought-leadership outreach tied to infectious disease prevention, surveillance, diagnostics, or clinical evidence rather than direct attendee assumptions |
| Overall lead quality | Medium to High | Good strategic-fit event for medical and public health sellers, but weaker for verified attendee-list extraction |
| Best use case | High | Role-based outbound prospecting, webinar-adjacent messaging, KOL engagement, and segment-specific Apollo campaigns |
| Limitations / risks | High caution required | No verified current-year attendee roster, buyer directory, or organization list in the reviewed source; supplied event details conflict with official page content |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Biotechnology; Medical Devices; Research; Higher Education; Government Administration; Nonprofit Organization Management; Information Technology & Services; Health, Wellness & Fitness | Covers the most likely attendee-side organizations relevant to infectious disease and public health |
| Departments | Medical, Clinical Operations, Research, Laboratory, Public Health, Medical Affairs, Partnerships, Innovation, IT, Quality | Find both direct users and decision influencers |
| Seniority | Director; VP; Head; C-Level; Manager; Partner; Principal | Prioritize buyers and strong technical influencers |
| Job titles | Infectious Disease Director; Chief Medical Officer; Medical Affairs Director; Head of Epidemiology; Laboratory Director; Principal Investigator; Infection Prevention Director; Public Health Program Manager; Clinical Research Manager; Global Health Partnerships Director | Directly aligned with event content and likely attendance profile |
| Geography | Europe; United Kingdom; North America; Middle East; Asia Pacific | Matches the likely international footprint of a global webinar audience |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Captures hospitals, universities, biotech firms, agencies, and established medtech/pharma groups |
| Keywords | infectious disease, epidemiology, outbreak response, public health, vaccination, immunization, microbiology, virology, infection control, disease surveillance, antimicrobial resistance, molecular diagnostics | Improves role and account relevance for outbound lists |
| Technologies, if relevant | LIMS, EHR, clinical analytics, public health reporting, molecular diagnostics platforms | Useful for solution providers with healthcare IT or lab integration offerings |
| Revenue range, if relevant | Mid-market to enterprise; public agencies and large nonprofits where applicable | Helps separate academic startups from scaled buyers and institutional accounts |
| Company type | Hospitals, universities, research institutes, pharmaceutical companies, biotech firms, public health agencies, NGOs | Narrows outreach to organizations most aligned with the event profile |
Suggested Apollo Search Logic: Use combinations such as: ("infectious disease" OR epidemiology OR "infection prevention" OR microbiology OR virology OR "public health" OR vaccination OR immunization OR "disease surveillance") AND (Director OR Head OR VP OR Chief OR Manager OR Principal Investigator) within Hospital & Health Care, Pharmaceuticals, Biotechnology, Medical Devices, Research, Higher Education, and Government Administration accounts across Europe and other target regions.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Conference Series Infectious Diseases Europe Page | Official event website | Verified event title on the page reviewed, webinar format, dates August 27–28, 2026, organizer name, conference theme, and general audience profile | High for event basics published on the page |
| User-supplied event details | Secondary input | Provided title, Budapest location, Radisson Hotel Budapest, BudaPart, and September 24–25, 2026 dates | Not verified against the reviewed official source |
Report prepared using the official webpage content provided as the primary source of truth. Where current-year buyer, exhibitor, sponsor, speaker, venue, city, or attendance records were not publicly confirmed in the reviewed source, the report has been labeled accordingly and avoids unsupported attendance claims.
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 8th European Congress on Infectious Diseases — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds